Filters: keyword is Electroencephalography [Clear All Filters]
- 2009
Changes in GABAA receptor properties in amygdala kindled animals: in vivo studies using [11C]flumazenil and positron emission tomography,
Epilepsia, vol. 50, no. 1, pp. 88-98. DOI
- 2008
Pharmacokinetic/pharmacodynamic modelling of the EEG effects of opioids: the role of complex biophase distribution kinetics,
Eur J Pharm Sci, vol. 34, no. 2-3, pp. 149-63. DOI
- 2007
Decreased Efficacy of GABAA-receptor modulation by midazolam in the kainate model of temporal lobe epilepsy,
Epilepsia, vol. 48, no. 7, pp. 1378-87. DOI
Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG,
Br J Pharmacol, vol. 151, no. 5, pp. 713-20. DOI
Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux,
Br J Pharmacol, vol. 151, no. 5, pp. 701-12. DOI
- 2006
Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery,
Anesthesiology, vol. 104, no. 3, pp. 466-74. DOI
Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery,
Anesthesiology, vol. 105, no. 6, pp. 1135-46. DOI
- 2004
Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat,
Epilepsia, vol. 45, no. 5, pp. 424-35. DOI
- 2003
Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo,
J Pharmacol Exp Ther, vol. 304, no. 3, pp. 1251-7. DOI
Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction,
Epilepsia, vol. 44, no. 3, pp. 329-38. DOI
Mechanism-based pharmacokinetic/pharmacodynamic modeling of the electroencephalogram effects of GABAA receptor modulators: in vitro-in vivo correlations,
J Pharmacol Exp Ther, vol. 304, no. 1, pp. 88-101. DOI
- 2002
Mechanism-based pharmacokinetic-pharmacodynamic modeling of concentration-dependent hysteresis and biphasic electroencephalogram effects of alphaxalone in rats,
J Pharmacol Exp Ther, vol. 302, no. 3, pp. 1158-67.
Neuroactive steroids differ in potency but not in intrinsic efficacy at the GABA(A) receptor in vivo,
J Pharmacol Exp Ther, vol. 303, no. 2, pp. 616-26. DOI
Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol,
J Pharmacokinet Pharmacodyn, vol. 29, no. 3, pp. 235-50.
Electroencephalography parameters as biomarkers: extrapolation from laboratory animals to humans,
Methods Find Exp Clin Pharmacol, vol. 24 Suppl D, pp. 63-4. DOI
Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: focus on preclinical steps,
Methods Find Exp Clin Pharmacol, vol. 24 Suppl D, pp. 127-8. DOI
- 2001
Pharmacokinetic-pharmacodynamic modelling in the early development phase of anti-psychotics: a comparison of the effects of clozapine, S 16924 and S 18327 in the EEG model in rats,
Br J Pharmacol, vol. 132, no. 1, pp. 151-8. DOI
- 2000
Mechanism-based modeling of functional adaptation upon chronic treatment with midazolam,
Pharm Res, vol. 17, no. 3, pp. 321-7.
Effect of amygdala kindling on the central nervous system effects of tiagabine: EEG effects versus brain GABA levels,
Br J Pharmacol, vol. 130, no. 5, pp. 1037-44. DOI
Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship,
Eur J Pharm Sci, vol. 12, no. 2, pp. 141-50. DOI
- 1999
Mechanism-based modeling of adaptive changes in the pharmacodynamics of midazolam in the kindling model of epilepsy,
Pharm Res, vol. 16, no. 11, pp. 1702-9.
Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam,
J Pharmacol Exp Ther, vol. 289, no. 2, pp. 1067-74.
Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats,
Br J Pharmacol, vol. 127, no. 1, pp. 227-35. DOI
Application of a combined "effect compartment/indirect response model" to the central nervous system effects of tiagabine in the rat,
J Pharmacokinet Biopharm, vol. 27, no. 3, pp. 301-23.


